![]()
|
Silantes uses a new technology to produce biomolecules such as amino acids, nucleotides, peptides, proteins and DNA labeled with the stable isotopes 2H and 13C and 15N. Silantes has a staff of highly skilled scientists from
the fields of molecular biology, microbiology, biochemistry and biotechnology
who can provide flexible, intelligent and customer-oriented responses
to the needs of science and industry.
|
||
|
|
Silantes was founded in 1998 by a researcher from the German Max-Planck-Institute, who developed a new method for the production of stable isotope labeled biomolecules based on chemolithoautotrophic bacteria (patent pending). This technology exploits the fact that chemolithoautotrophic bacteria can metabolise inorganic carbon in a pathway similar to that of green plants. Chemolithoautotrophic bacteria combine the advantage of green plants of being able to assimilate CO2 with the advantages of bacteria of being more productive and reliable as well as capable of expressing heterologous proteins. The labeled chemolithoautotrophic bacteria cells are used as a factory to produce the stable isotope labeled biomolecules of choice. The technology provides an outstanding homogeneity of components labeled with stable isotopes, especially in the area of triple labeled (2H, 13C and 15N) biomolecules.
|
|
|
|
Silantes currently offers a wide variety of biomolecules
labeled in any combination of the stable isotopes 2H, 13C and 15N:
|
|
| Silantes technology for in vivo enrichment
of stable isotopes in biomolecules is vastly superior to established
methods with respect to reliability, speed, quality, versatility and
cost. Silantes is a young dynamic company with a highly motivated and flexible team eager to assist customers in finding custom-made solutions. Silantes offers a comprehensive range of services which are unique world-wide. We look forward to discussing your special applications with you and assisting you in finding optimal solutions. |